In a recent study published in The Lancet – the Pharmacogenomic Testing for Preventing Adverse Drug Reactions (PREPARE) study – […]
In a recent study, an international team has found thousands of new regulatory regions that control the expression of disease-linked […]
Michael Friend is the co-founder and CEO of the Minority Coalition for Precision Medicine, which aims to eradicate health disparities […]
Researchers have developed a platform of pan-cancer tumour organoids and a neural-network-based drug assay, that has the potential to advance […]
Researchers have shown that optimising early life nutrition can reduce the risk of adult cardiometabolic disease in genetically predisposed infants, […]
At the Festival of Genomics and Biodata 2021, we were joined by Stephen F. Kingsmore (President and CEO, Rady Children’s […]
As we move towards an ever more personalised healthcare system, genomics is at the heart of what makes an individual […]
Ahead of our virtual panel discussion on the promises and pitfalls of precision medicine trials: now and in the future […]
Sano Genetics, Zetta Genomics and Genomics England have partnered to develop a novel system to allow rare disease patients and […]
Earlier this week, Stephane Budel wrote an article about the role diagnostic technologies will play in the future of precision medicine. […]
